A rating of 27 puts Revance Therapeutics Inc (RVNC) near the bottom of the Biotechnology industry according to InvestorsObserver. Revance Therapeutics Inc's score of 27 means it scores higher than 27% of stocks in the industry. Revance Therapeutics Inc also received an overall rating of 38, putting it above 38% of all stocks. Biotechnology is ranked 20 out of the 148 industries.
RVNC has an Overall Score of 38. Find out what this means to you and get the rest of the rankings on RVNC!